IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
62 hedge funds and large institutions have $742M invested in IGM Biosciences in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
+12
Holders Change %
+24%
% of All Funds
1.37%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
21
Increased
16
Reduced
17
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Alkeon Capital Management
New York
|
+$27.2M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$15.1M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
+$11.2M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$9.16M |
| 5 |
BlackRock
New York
|
+$6.38M |
Top Sellers
| 1 |
AG
Artal Group
Luxembourg
|
-$5.72M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.57M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$3.82M |
| 4 |
EP
Eversept Partners
New York
|
-$3.08M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$2.43M |
